Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
The Committee considers that the actual benefit of ALTIM remains substantial in rheumatological diseases : - In intra-articular injection: inflammatory arthritis, advanced osteoarthritis. - In periarticular injection: tendinitis, bursitis. - In injection of soft tissue: talalgia, carpal tunnel syndrome, Dupuytren's contracture. |
| Unspecified |
The Committee does not make any comment on the actual benefit of ALTIM in the epidural injection indication : radiculalgia, pending the re-assessment of ALTIM 3.75 mg/1.5 ml suspension for injection an d HYDROCORTANCYL 2.5 % suspension for injection in this single indication. |
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
acAYz4Xn3ZkneWYW
